Regeneus to present at AusBiotech 2018 - Australia's Life Sciences Conference

Wednesday, 31 October 2018

Regeneus Ltd (ASX: RGS), a clinical-stage regenerative medicine company, is pleased to announce John Martin, CEO, will present at the AusBiotech 2018 Conference today.

The annual AusBiotech conference brings together Australian and international biotech leaders and stakeholders. For more than three decades, the event has created a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally. AusBiotech is dedicated to consolidating this growth.

John Martin was invited to present as part of the Regenerative Medicine Stream. His session will focus on the successful translation and commercialisation of novel regenerative medicines by Australian companies. MTPConnect, the Australian Government’s medtech and pharma growth centre, launched a report entitled ‘Regenerative Medicine: Opportunities for Australia’ at the beginning of the session. The report was produced in collaboration with AusBiotech’s Regenerative Medicine Advisory Group, of which John Martin is a member, as well as other key stakeholders from industry and the research sector.

The following are specific details regarding Regeneus’ presentation:
Event: AusBiotech 2018
Date: 31 October 2018
Time: 2.30pm (AEST)
Location: Room 2, Brisbane Convention and Exhibition Centre, Southbank, Brisbane